| Literature DB >> 24294234 |
Weifeng Shi1, Kun Li, Yun Ji, Qinbo Jiang, Yuyue Wang, Mei Shi, Zuhuang Mi.
Abstract
Clinical isolates of carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae) strains are being increased worldwide. Five pan-resistant K. pneumoniae strains have been isolated from respiratory and ICU wards in a Chinese hospital, and reveal strong resistance to all β-lactams, fluoroquinolones and aminoglycosides. Totally 27 β-lactamase genes and 2 membrane pore protein (porin) genes in 5 K. pneumoniae strains were screened by polymerase chain reaction (PCR). The results indicated that all of 5 K. pneumoniae strains carried blaTEM-1 and blaDHA-1 genes, as well as base deletion and mutation of OmpK35 or OmpK36 genes. Compared with carbapenem-sensitive isolates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the resistant isolates markedly lacked the protein band of 34-40 kDa, which might be the outer membrane proteins of OmpK36 according to the electrophoresis mobility. In addition, the conjugation test was confirmed that blaDHA-1 mediated by plasmids could be transferred between resistant and sensitive strains. When reserpine (30 μg/mL) and carbonyl cyanide m-chlorophenylhydrazone (CCCP) (50 μg/mL) were added in imipenem and meropenem, the MICs had no change against K. pneumoniae strains. These results suggest that both DHA-1 β-lactamase and loss or deficiency of porin OmpK36 may be the main reason for the cefoxitin and carbapenem resistance in K. pneumoniae strains in our hospital.Entities:
Keywords: AmpC β-Lactamase; Klebsiella pneumoniae; Porin; molecular biology
Mesh:
Substances:
Year: 2013 PMID: 24294234 PMCID: PMC3833140 DOI: 10.1590/S1517-83822013000200015
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Primers used in this study.
| Target genes | Primer sequence (3′ → 5′) | Size (bp) | GenBank accession no. of reference |
|---|---|---|---|
| Class A β-lactamases | |||
| TEM | P1: AGGAAGAGTATGATTCAACA | ||
| P2: CTCGTCGTTTGGTATGGC | 535 bp | X54604 | |
| SHV | P1: TGCGCAAGCTGCTGACCAGC | ||
| P2: TTAGCGTTGCCAGTGCTCGA | 305 bp | AY326946 | |
| CTX-M-1 group | P1: ATGGTTAAAAAATCACTGCGC | ||
| P2: TCCCGACGGCTTTCCGCCTT | 833 bp | GU125714 | |
| CTX-M-2 group | P1: ATGATGACTCAGAGCATTCG | ||
| P2: TCCCGACGGCTTTCCGCCTT | 833 bp | AY750915 | |
| CTX-M-8 group | P1: ATGATGAGACATCGCGTTAAGCGG | ||
| P2: TTAATAACCGTCGGTGACGATTTTCGCG | 876 bp | AF189721 | |
|
| |||
| CTX-M-9 group | P1: CGGCCTGTATTTCGCTGTTG | ||
| P2: TCCCGACGGCTTTCCGCCTT | 793 bp | AB205197 | |
| CTX-M-25 group | P1: ATGATGAGAAAAAGCGTAAGGCGGGCG | ||
| P2: TCCCGACGGCTTTCCGCCTT | 876 bp | AY157676 | |
| PER | P1: AGTCAGCGGCTTAGATA | ||
| P2: CGTATGAAAAGGACAATC | 978 bp | AJ621265 | |
| GES | P1: ATGCGCTTCATTCACGCAC | ||
| P2: CTATTTGTCCGTGCTCAGG | 846 bp | AY219651 | |
| VEB | P1: GCGGTAATTTAACCAGA | ||
| P2: GCCTATGAGCCAGTGTT | 961 bp | AY536743 | |
| CARB | P1: AAAGCAGATCTTGTGACCTATTC | ||
| P2: TCAGCGCGACTGTGATGTATAAAC | 588 bp | S46063 | |
| KPC | P1: ATGTCACTGTATCGCCGTCTA | ||
| P2: TTACTGCCCGTTGACGCCCAA | 882 bp | GU086225 | |
| LAP | P1: ATGAAAAAGATCCGCCTTATTATAA | ||
| P2: TTACCAGTTCTTAATTACTGAATC | 858 bp | EF026092 | |
|
| |||
| Class B β-lactamases | |||
| IMP | P1: CGGCCGCAGGAGAGGCTTT | ||
| P2: AACCAGTTTTGCCTTACCAT | 587 bp | AJ223604 | |
| VIM | P1: ATTCCGGTCGGAGAGGTCCG | ||
| P2: GAGCAAGTCTAGACCGCCCG | 633 bp | AY509609 | |
| SPM | P1: CTGCTTGGATTCATGGGCGCG | 784 bp | AY341249 |
| P2: CCTTTTCCGCGACCTTGCTCG | |||
| NDM | P1: TCAGCGCAGCTTGTCGGCCA | 813 bp | HQ738352 |
| P2: ATGGAATTGCCCAATATTATGCA | |||
|
| |||
| Class C β-lactamases | |||
| LEN | P1: ATGCGTTATATTCGCCTGTG | 591 bp | AM850914 |
| P2: GGCGCTCAGATGCTGCGC | |||
| OKP | P1: AAGCGCTTCCCGGCGACGTG | 362 bp | AM051141 |
| P2: TTAGCGTTGCCAGTGCTCGA | |||
| DHA | P1: AACTTTCACAGGTGTGCTGGGT | 405 bp | AY585202 |
| P2: CCGTACGCATACTGGCTTTGC | |||
| ACT | P1: TCGGTAAAGCCGATGTTGCGG | 303 bp | EF508682 |
| P2: CTTCCACTGCGGCTGCCAGTT | |||
| MOX | P1: GCTGCTCAAGGAGCACAGGAT | 520 bp | EU515248 |
| P2: CACATTGACATAGGTGTGGTG | |||
| ACC | P1: ACAGCCTCAGCAGCCGGTTA | 345 bp | AJ133121 |
| P2: TTCGCCGCAATCATCCCTAG | |||
| FOX | P1: AACATGGGGTATCAGGGAGAT | 190 bp | AY034848 |
| P2: CAAAGCGCGTAACCGGATTGG | |||
|
| |||
| Class D β-lactamases | |||
| OXA-1 group | P1: CTGTTGTTTGGGTTTCGCAAG | 440 bp | GQ438248 |
| P2: CTTGGCTTTTATGCTTGATG | |||
| OXA-2 group | P1: CAGGCGCTGTTCGTGATGAGTT | 233 bp | FJ855130 |
| P2: GCCTTCTATCCAGTAATCGCC | |||
| OXA-10 group | P1: GTCTTTCAAGTACGGCATTA | 822 bp | AY509609 |
| P2: GATTTTCTTAGCGGCAACTTA | |||
|
| |||
| Porin | |||
| ompK35 | P1: ATGATGAAGCGCAATATTCTGGCAGTGG | 684 bp | GU945384 |
| P2: TCGGCTTTGTCGCCATTGCCGTCA | |||
| ompK36 | P1: ATGAAAGTTAAAGTACTGTCCCTC | 1076 bp | HM000057 |
| P2: GCCGGTATCTCTACCGACGAC | |||
MICs of β-lactams, fluoroquinolones and aminoglycosides against K. pneumoniae strains.
| Antimicrobial agents | MIC (μg/mL) | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Piperacillin | > 256 | > 256 | > 256 | > 256 | > 256 | 1 |
| Piperacillin/sulbactam | > 256 | > 256 | > 256 | > 256 | > 256 | 1 |
| Amoxicillin/clavulanic acid | > 256 | > 256 | > 256 | > 256 | > 256 | 0.5 |
| Cefoxitin | > 256 | > 256 | > 256 | > 256 | > 256 | 4 |
| Cefotaxime | > 256 | > 256 | > 256 | > 256 | > 256 | 0.25 |
| Cefoperazone/sulbactam | > 256 | > 256 | > 256 | > 256 | > 256 | ≤ 0.125 |
| Cefepime | 128 | 128 | > 256 | > 256 | 128 | ≤ 0.125 |
| Aztreonam | > 256 | > 256 | > 256 | > 256 | > 256 | ≤ 0.125 |
| Imipenem | > 32 | > 32 | > 32 | > 32 | > 32 | ≤ 0.125 |
| Meropenem | > 32 | > 32 | > 32 | 32 | 32 | ≤ 0.125 |
| Ciprofloxacin | > 128 | > 128 | > 128 | 64 | 128 | ≤ 0.125 |
| Levofloxacin | > 128 | > 128 | > 128 | 64 | 64 | ≤ 0.125 |
| Gentamicin | > 128 | > 128 | > 128 | > 128 | 128 | ≤ 0.125 |
| Amikacin | > 128 | > 128 | > 128 | 128 | 128 | ≤ 0.125 |
Kp01, Kp02, Kp03, Kp04 and Kp05: carbapenem-resistant K. pneumoniae strains.
Figure 1Three-dimensional test for five strain isolates. (1A) Enhanced growth of E.coli ATCC25922 was observed near agar slits containing enzyme extracts of Kp01, Kp02 and E. cloacae 029 M. Except for ATCC700603, all of them were AmpC producers. (1B) Kp03, Kp04, Kp05 and E. cloacae 029 M could interfere with the growth of E. coli ATCC25922.
Expression of two porins in five K. pneumoniae strains.
| Strains | ||||
|---|---|---|---|---|
| + | + | Base deletion | Base deletion | |
| + | + | Insertion | Base deletion | |
| + | + | Base deletion | Base deletion | |
| + | + | Insertion | Mutation | |
| + | + | Insertion | Base deletion |
The antimicrobial susceptibility of transconjugants.
| Antimicrobial agents | MIC (μg/mL) | |||
|---|---|---|---|---|
|
| ||||
| Tr01 | Tr02 | Tr03 | Tr05 | |
| Piperacillin | 8 | 16 | 4 | 8 |
| Piperacillin/sulbactam | 4 | 8 | 8 | 4 |
| Amoxicillin/clavulanic acid | 4 | 8 | 4 | 4 |
| Cefotaxime | 0.5 | 1 | 0.5 | 1 |
| Cefoperazone/sulbactam | 0.25 | 0.125 | 0.125 | 0.25 |
| Aztreonam | 0.25 | 0.25 | 0.25 | 0.5 |
| Cefepime | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 |
| Imipenem | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 |
| Meropenem | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 |
| Ciprofloxacin | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 | ≤ 0.125 |
| Amikacin | 0.25 | ≤ 0.125 | 0.25 | 0.25 |
Transconjugants: Tr.
Figure 2SDS-PAGE of outer membrane proteins. M: Marker; S1: ATCC700603; S2: sensitive strain.